Disc Medicine, Inc. (IRON)
NASDAQ: IRON · IEX Real-Time Price · USD
28.53
+0.69 (2.48%)
May 1, 2024, 4:00 PM EDT - Market closed
Disc Medicine Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
74
Market Cap
704.15M USD
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 0 | - | - |
| Dec 31, 2022 | 0 | - | - |
| Dec 31, 2021 | 0 | - | - |
| Dec 31, 2020 | 0 | - | - |
| Dec 31, 2019 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Varex Imaging | 877.80M |
| Pharming Group | 272.57M |
| Evolus | 202.09M |
| Silk Road Medical | 177.13M |
| Atrion | 169.33M |
| OrthoPediatrics | 148.73M |
| Y-mAbs Therapeutics | 84.82M |
| Autolus Therapeutics | 1.70M |
IRON News
- 4 weeks ago - Top 3 Health Care Stocks You'll Regret Missing This Month - Humana (NYSE:HUM), Disc Medicine (NASDAQ:IRON) - Benzinga
- 4 weeks ago - Disc Reports Topline Results from Phase 2 AURORA Study of Bitopertin in Patients with Erythropoietic Protoporphyria (EPP) - GlobeNewsWire
- 5 weeks ago - Disc Medicine Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update - GlobeNewsWire
- 2 months ago - Disc Medicine to Participate in the Leerink Partners Global Biopharma Conference 2024 - GlobeNewsWire
- 2 months ago - Disc Medicine Expands Leadership Team with Appointment of Industry Veteran Pamela Stephenson, MPH as Chief Commercial Officer - GlobeNewsWire
- 2 months ago - FDA Grants Orphan Drug Designation to 9MW3011 - PRNewsWire
- 2 months ago - Disc Medicine Receives FDA Fast Track Designation for DISC-0974 for the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease - GlobeNewsWire
- 2 months ago - Disc Medicine Receives FDA Orphan Drug Designation for DISC-3405 for the Treatment of Polycythemia Vera - GlobeNewsWire